Appili Therapeutics Inc. (TSE:APL) Forecasted to Post FY2023 Earnings of ($0.10) Per Share
Appili Therapeutics Inc. (TSE:APL) Forecasted to Post FY2023 Earnings of ($0.10) Per Share
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Zacks Small Cap issued their FY2023 earnings estimates for Appili Therapeutics in a note issued to investors on Thursday, July 14th. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.
Appili治療公司(多倫多證券交易所股票代碼：APL-GET評級)--Zack Small Cap在7月14日星期四發給投資者的一份報告中發佈了他們對Appili治療公司2023財年的收益預期。Zack Small Cap分析師D·鮑茨預計，該公司今年的每股收益將達到0.10美元。扎克斯小盤股還發布了對Appili Treateutics 2024財年每股收益(0.07美元)和2025財年每股收益(0.06美元)的估計。
Appili Therapeutics Stock Performance
阿普利治療公司股票表現
Featured Articles
專題文章
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
- 金融服務公司Block股價在2022年下跌(-59%)
- 今天持有輝瑞公司的催化劑，明天就能實現進一步增長
- NVIDIA股票將在下半年創下紀錄
- 強生在動盪的一年裏繼續證明自己的價值
- MarketBeat：回顧一週7/11-7/15
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
獲得《阿普利治療日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Appili Treateutics和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。